Anagha Killedar

Anagha Killedar

Auto-generated profile, based on publicly available information

Anagha Killedar

Leeder Centre for Health Policy, Economics & Data, The University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2018 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
TLThomas Lung
Thomas Lung
SJStephen Jan
Stephen Jan
ETEng Joo Tan
Eng Joo Tan
AKAnagha Killedar
Anagha Killedar
AHAlison Hayes
Alison Hayes

8 June 2015 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AKAnagha Killedar
Anagha Killedar
MSMichael D Stutz
Michael D Stutz
ASAlexander P Sobinoff
Alexander P Sobinoff
CTChristopher G Tomlinson
Christopher G Tomlinson
TBTracy M Bryan
Tracy M Bryan
HPHilda Pickett
Hilda Pickett
The TERT-CLPTM1L region of chromosome 5p15.33 is a multi-cancer susceptibility locus that encodes the reverse transcriptase subunit, hTERT, of the telomerase enzyme. Numerous cancer-associated single-nucleotide polymorphisms (SNPs), including rs10069690, have been identified within the hTERT gene. The minor allele (A) at rs10069690 creates an additional splice donor site in intron 4 of hTERT, and is associated with an elevated risk of multiple cancers including breast and ovarian carcinomas. We previously demonstrated that the presence of this allele resulted in co-production of full length (FL)-hTERT and an alternatively spliced, INS1b, transcript. INS1b does not encode the reverse transcriptase domain required for telomerase enzyme activity, but we show here that INS1b protein retains its ability to bind to the telomerase RNA subunit, hTR. We also show that INS1b expression results in decreased telomerase activity, telomere shortening, and an increased telomere-specific DNA damage response (DDR). We employed antisense oligonucleotides to manipulate endogenous transcript expression in favor of INS1b, which resulted in a decrease in telomerase activity. These data provide the first detailed mechanistic insights into a cancer risk-associated SNP in the hTERT locus, which causes cell type-specific expression of INS1b transcript from the presence of an additional alternative splice site created in intron 4 by the risk allele. We predict that INS1b expression levels cause subtle inadequacies in telomerase-mediated telomere maintenance, resulting in an increased risk of genetic instability and therefore of tumorigenesis. Multiple cancer-associated single nucleotide polymorphisms (SNPs) associated with risk of a wide variety of cancers have been identified in the TERT-CLPTM1L region of 5p15.33, identifying this as a multi-cancer susceptibility locus. hTERT encodes the catalytic subunit of the enzyme telomerase, which is responsible for telomere length maintenance in the germline and in most immortalised cancer cells. To date, very little is known regarding the mechanisms by which specific hTERT SNPs predispose to cancer. In this study, we carried out detailed functional analyses on the intron 4 SNP rs10069690, which is associated with a small, but highly significant risk for many types of cancer. We show that the risk-associated minor allele of this SNP results in an hTERT mRNA splice variant, encoding a catalytically inactive protein which acts as a dominant negative inhibitor of telomerase activity and therefore decreases total telomerase activity. We propose that individuals who carry the rs10069690 minor allele have less telomerase activity in some cell types due to cell type-specific alternative splicing, which may result in slightly shorter telomeres, and hence an increased risk of genetic instability and tumorigenesis.

16 January 2020 in International Journal of Obesity
Verified
Journal Article
Closed access
AKAnagha Killedar
Anagha Killedar
TLThomas Lung
Thomas Lung
Stavros PetrouStavros Petrou
Stavros Petrou
ATArmando Teixeira-Pinto
Armando Teixeira-Pinto
ETEng Joo Tan
Eng Joo Tan
AHAlison Hayes
Alison Hayes

30 March 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
AHAlison Hayes
Alison Hayes
ETEng Joo Tan
Eng Joo Tan
AKAnagha Killedar
Anagha Killedar
TLThomas Lung
Thomas Lung
Objectives: To develop a model to predict future socioeconomic inequalities in body mass index (BMI) and obesity.Design: Microsimulation modelling using BMI data from adult participants of Australian Health Surveys, and published data on the relative risk of mortality in relation to BMI and socioeconomic position (SEP), based on education.Setting: Australia.Participants: 74 329 adults, aged 20 and over from Australian Health Surveys, 1995–2015.Primary and secondary outcome measures: The primary outcomes were BMI trajectories and obesity prevalence by SEP for four birth cohorts, born 10 years apart, centred on 1940, 1950, 1960 and 1970.Results: Simulations projected persistent or widening socioeconomic inequality in BMI and obesity over the adult life course, for all birth cohorts. Recent birth cohorts were predicted to have greater socioeconomic inequality by middle age, compared with earlier cohorts. For example, among men, there was no inequality in obesity prevalence at age 60 for the 1940 birth cohort (low SEP 25% (95% CI 17% to 34%); high SEP 26% (95% CI 19% to 34%)), yet for the 1970 birth cohort, obesity prevalence was projected to be 51% (95% CI 43% to 58%) and 41% (95% CI 36% to 46%) for the low and high SEP groups, respectively. Notably, for more recent birth cohorts, the model predicted the greatest socioeconomic inequality in severe obesity (BMI >35 kg/m2) at age 60.Conclusions: Lower SEP groups and more recent birth cohorts are at higher risk of obesity and severe obesity, and its consequences in middle age. Prevention efforts should focus on these vulnerable population groups in order to avoid future disparities in health outcomes. The model provides a framework for further research to investigate which interventions will be most effective in narrowing the gap in socioeconomic disparities in obesity in adulthood.

8 February 2021 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
AHAlison J. Hayes
Alison J. Hayes
JCJoseph P. Carrello
Joseph P. Carrello
PKPatrick J. Kelly
Patrick J. Kelly
AKAnagha Killedar
Anagha Killedar
LBLouise A. Baur
Louise A. Baur

3 October 2023 in Applied Health Economics and Health Policy
Verified
Journal Article
Open access
PDF file
RRRakhee Raghunandan
Rakhee Raghunandan
KHKirsten Howard
Kirsten Howard
SSSarah Smith
Sarah Smith
AKAnagha Killedar
Anagha Killedar
ECErin Cvejic
Erin Cvejic
AHAlison Hayes
Alison Hayes
Background Generic instruments such as the Pediatric Quality of Life Inventory™ v4.0 Generic Core Scales (PedsQL GCS) and Child Health Utility 9D (CHU9D) are widely used to assess health-related quality of life (HRQOL) of the general childhood population, but there is a paucity of information about their psychometric properties in children with specific health conditions. This study assessed psychometric properties, including acceptability, reliability, validity, and responsiveness, of the PedsQL GCS and the CHU9D in children and adolescents with a range of common chronic health problems. Methods We used data from the Longitudinal Study of Australian Children (LSAC), for children aged 10–17 years with at least one of the following six parent-reported health conditions: asthma, anxiety/depression, attention deficit hyperactivity disorder (ADHD), autism/Asperger’s, epilepsy, and type 1 diabetes mellitus. The LSAC used parent proxy-reported PedsQL GCS and child self-reported CHU9D assessments. The performance of each instrument (PedsQL GCS and CHU9D) for each psychometric property (acceptability, reliability, validity, and responsiveness) was assessed against established criteria. Results The study sample included 7201 children and adolescents (mean age = 14 years; range 10.1–17.9 years; 49% female) with 15,568 longitudinal observations available for analyses. Across the six health conditions, acceptability of the PedsQL GCS was high, while acceptability for the CHU9D was mixed. Both the PedsQL GCS and CHU9D showed strong internal consistency (Cronbach’s alpha range: PedsQL GCS = 0.70–0.95, CHU9D = 0.76–0.84; item-total correlations range: PedsQL GCS = 0.35–0.84, CHU9D = 0.32–0.70). However, convergent validity for both the PedsQL GCS and CHU9D was generally weak (Spearman’s correlations ≤ 0.3). Known group validity was strong for the PedsQL GCS (HRQOL differences were detected for children with and without asthma, anxiety/depression, ADHD, autism/Asperger’s, and epilepsy). CHU9D was only able to discriminate between children with and without anxiety/depression, ADHD, and autism/Asperger’s. The responsiveness of both the PedsQL GCS and CHU9D was variable across the six conditions, and most of the estimated effect sizes were relatively small (< 0.5). Conclusion This study expands the evidence base of psychometric performance of the PedsQL GCS and CHU9D and can aid in appropriate HRQOL instrument selection for the required context by researchers and clinicians.